D S Stephens
Overview
Explore the profile of D S Stephens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
3293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dretler A, Rouphael N, Stephens D
Hum Vaccin Immunother
. 2018 Mar;
14(5):1146-1160.
PMID: 29543582
The control of meningitis, meningococcemia and other infections caused by Neisseria meningitidis is a significant global health challenge. Substantial progress has occurred in the last twenty years in meningococcal vaccine...
2.
Stephens D, Ahmed R, Orenstein W
Vaccine
. 2014 Jan;
32(9):1029-30.
PMID: 24412350
No abstract available.
3.
Tzeng Y, Martin L, Stephens D
Epidemiol Infect
. 2013 Apr;
142(1):187-90.
PMID: 23574798
Neisseria meningitidis is transmitted through the inhalation of large human respiratory droplets, but the risk from contaminated environmental surfaces is controversial. Compared to Streptococcus pneumoniae and Acinetobacter baumanni, meningococcal viability...
4.
Cantey P, Stephens D, Rimland D
HIV Med
. 2005 Jul;
6(4):253-9.
PMID: 16011530
Despite advances in the treatment of HIV disease, the incidence and mortality of invasive cryptococcal disease remain significant. A matched, case-control study was performed to examine the impact of highly...
5.
JERNIGAN J, Stephens D, Ashford D, Omenaca C, Topiel M, Galbraith M, et al.
Emerg Infect Dis
. 2001 Dec;
7(6):933-44.
PMID: 11747719
From October 4 to November 2, 2001, the first 10 confirmed cases of inhalational anthrax caused by intentional release of Bacillus anthracis were identified in the United States. Epidemiologic investigation...
6.
Hyde T, Gay K, Stephens D, Vugia D, Pass M, Johnson S, et al.
JAMA
. 2001 Oct;
286(15):1857-62.
PMID: 11597287
Context: Macrolide antibiotics, including erythromycin, clarithromycin, and azithromycin, are the mainstays of empirical pneumonia therapy. Macrolide resistance among Streptococcus pneumoniae, the most common cause of community-acquired pneumonia, is increasing in...
7.
Rahman M, Kahler C, Stephens D, Carlson R
Glycobiology
. 2001 Aug;
11(8):703-9.
PMID: 11479281
The inner core structures of the lipooligosaccharides (LOS) of Neisseria meningitidis are potential vaccine candidates because both bactericidal and opsonic antibodies can be generated against these epitopes. In an effort...
8.
Gay K, Stephens D
J Infect Dis
. 2001 Jun;
184(1):56-65.
PMID: 11398110
Macrolide resistance associated with macrolide efflux (mef) has rapidly increased in Streptococcus pneumoniae. We defined the genetic structure and dissemination of a novel mefE-containing chromosomal insertion element. The mefE gene...
9.
Kahler C, Martin L, Tzeng Y, Miller Y, Sharkey K, Stephens D, et al.
Infect Immun
. 2001 May;
69(6):3597-604.
PMID: 11349019
We have located a locus, pgl, in Neisseria meningitidis strain NMB required for the glycosylation of class II pili. Between five and eight open reading frames (ORFs) (pglF, pglB, pglC,...
10.
Rosenstein N, Perkins B, Stephens D, Popovic T, Hughes J
N Engl J Med
. 2001 May;
344(18):1378-88.
PMID: 11333996
No abstract available.